title: PEGylation--a well-proven strategy for the improvement of recombinant drugs.
abstract: Protein and peptide drugs hold great promise as therapeutic agents. But there are shortcomings: Many recombinant proteins are quickly degraded by proteolytic enzymes or are rapidly cleared by kidney filtration resulting in a short circulating half-life. Additionally they are prone to be recognized by the immune system resulting in the generation of neutralizing and non-neutralizing antibodies. PEGylation, a process by which polyethylene glycol chains are attached to protein and peptide drugs, can overcome these and other shortcomings. By increasing the molecular mass of proteins and peptides and shielding them from proteolytic enzymes, PEGylation primarily improves pharmacokinetics and helps to prevent adverse drug reactions.
authors.forename: I
authors.initials: I
authors.lastname: Zündorf
authors.forename: T
authors.initials: T
authors.lastname: Dingermann
mesh_terms: D000818:Animals; D002626:Chemistry, Pharmaceutical; D015195:Drug Design; D004798:Enzymes / Q000737:chemistry; D006801:Humans; D011092:Polyethylene Glycols / Q000737:chemistry*; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D013438:Sulfhydryl Compounds / Q000737:chemistry
chemical_list: D004798:Enzymes; D011994:Recombinant Proteins; D013438:Sulfhydryl Compounds; D011092:Polyethylene Glycols